How ACA marketplace plans handle formulary exceptions, prior authorization, and step therapy when a drug isn’t on the formulary
ACA marketplace drug coverage usually turns on three related tools: the formulary, prior authorization, and step therapy. If a prescribed drug is not on the plan’s formulary, coverage is not automatically impossible. But it is not automatic either. The next step is often some form of exception request, along with medical review by the plan.
This matters because ACA coverage decisions affect whether someone can enroll and keep exchange coverage, and CMS notes that exchange eligibility and appeal determinations are part of the ACA administrative framework. Per a Federal Register notice from CMS, exchange-related eligibility systems are used for enrollments, affordability programs, exemptions, renewals, and appeal determinations. That does not create a drug coverage rule by itself. It does show that ACA marketplace coverage sits inside a formal review and appeal structure, not an informal customer service process.
Comparison: what each tool does
| Coverage tool | What it means | What happens when the drug is off formulary | What the enrollee usually needs to show |
|---|---|---|---|
| Formulary | The plan’s list of covered drugs, usually tied to cost sharing and utilization rules. | If the drug is absent, the plan usually denies routine coverage unless an exception is approved. | Why the non-formulary drug is medically appropriate under the plan’s process. |
| Prior authorization | Advance approval before the plan pays. | The plan can still require review even if an exception pathway exists. | Clinical justification, records, and prescriber support. |
| Step therapy | A rule that requires trying another covered drug first. | The plan often asks whether covered alternatives were tried, failed, or are not suitable. | Evidence that the preferred step drug is not appropriate for the patient. |
| Appeal | Formal review of a denial or unfavorable decision. | The enrollee can challenge the plan’s refusal to cover the off-formulary drug. | The medical reason the denial should be reversed under the plan’s rules. |
For non-formulary drugs, the exception process is usually the starting point
If a marketplace plan does not list a drug on its formulary, the standard coverage path is usually blocked. The exception process is what asks the plan to treat the drug as coverable despite its absence from the list. In practice, that request is usually built around the prescriber’s statement that covered alternatives are not suitable, would not work as intended, or would create a clinical problem for that patient.
The key distinction is simple: a formulary gives the default answer, while an exception request asks the plan for a case-specific override. Not a rewrite of the whole benefit design. The plan is not deciding whether to add the drug for everyone. It is deciding whether to cover it for one enrollee under its exception process.
Prior authorization can still apply after that
People often treat prior authorization and formulary exceptions as the same thing. They are connected, but they are not identical. A formulary exception asks whether an off-formulary drug can be considered for coverage. Prior authorization asks whether the plan approves payment based on medical criteria before the prescription is filled or paid.
Drug Channels describes prior authorization execution as increasingly important when access tightens and utilization management expands. That framing fits the marketplace context. If a drug is off formulary, the plan often requires detailed documentation, and the quality of the submission can shape the outcome. Missing chart notes, incomplete diagnosis information, or a weak explanation of prior treatment history can slow review or lead to denial.
For pharmacists and benefits teams, the operational point is straightforward. A claim rejection at the pharmacy counter can reflect more than one issue at once: non-formulary status, unmet prior authorization requirements, or both. The fix depends on identifying which rule fired first.
Step therapy works differently because it centers on the alternatives
Step therapy is the tool plans use when they want a covered alternative tried before they approve another drug. When the requested drug is not on formulary, step therapy can become part of the exception review. The plan often asks whether a formulary option has already been tried, whether it failed, or whether there is a documented reason to avoid it.
That is where the difference between an exception and step therapy matters. An exception focuses on the non-formulary drug itself. Step therapy focuses on the alternatives the plan prefers first. A strong request usually addresses both. It does not just say, “cover this drug.” It explains why the preferred covered options do not fit the patient’s medical situation.
If the request is denied, the appeal has to answer the denial
If the plan denies the request, the next step is usually an appeal through the plan’s formal process. The CMS Federal Register notice confirms that ACA exchange administration includes appeal determinations. For enrollees, that means the review structure is part of the exchange system, not just a courtesy.
An effective appeal is usually narrower and more evidence-based than an initial request. It should match the denial reason. If the denial says no trial of covered alternatives was documented, the appeal should answer that point directly. If the denial says information was missing, the appeal should fill the gap instead of repeating the same submission.
Cost pressure makes all of this feel less abstract
KFF Health News reports that ACA enrollment fell by nearly 3 million this year to about 19.2 million, and that average premium payments and deductibles increased. For people who stay enrolled, tighter household budgets can make drug coverage barriers feel sharper. A non-formulary denial is not just administrative friction. It can affect whether treatment is affordable at all.
That does not mean every off-formulary request gets approved. It does mean the process works better when approached methodically. First identify whether the problem is non-formulary status, prior authorization, or step therapy. Then match the submission to that rule. If denied, use the appeal process tied to the plan and exchange framework.
Disclaimer: This article is for general educational purposes only and is not medical, legal, or insurance advice. Coverage rules vary by plan and state. Patients should check their plan documents and speak with their prescriber, pharmacist, or plan for guidance on a specific drug request.